The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Https://www.mskcc.org/cancer-care/doctors/alan-ho
My Specialties
Head & Neck Cancers
Mouth Cancer
Salivary Gland Cancer
View all
MSK have added another co-investigator to #AVCT’s trial.
It was led by Tap and Movva.
Ho has been added as a second co-investigator, alongside Movva.https://x.com/RAH00084/status/1758436259075067928?s=20
From Tom on Twitter .....https://twitter.com/tom_the_bomb__/status/1757159918618976330
This a game changer I have no doubt, for the patients in particular and the industry as a whole.
From what I am seeing the platform has established it's safety profile in administering (STS) chemo with little or greatly reduced side effects, huge in itself.
There are signs of efficacy in the limited data already published which would be the Cherry but we also need to add to that the potential to create new patents on existing Chemo that is either coming to the end of it's patent protection or been binned due to toxicity issues.
Looking forward to Al & Team unwrapping more the parcel next week.
Couldn't agree more.
Been a big week for Novartis I suspect Avacta are wating there turn ;)
"The big money is not in the buying and the selling, but in the waiting." Charlie
Been steady accumulation by Mr Unknown in the background, seems to be helping. & good to see.
Strength is relevant. Resistance is futile.
They can also have mine for £134 who's buying :)
Is it just me, all I see is US & UK what about the rest of the world " They're immune to Prostate cancer " ?
What's going on ?????
Looks like cancer treatment is about to be turned on it's head, hard to take it all in.
Congrats to all involved.
This could be bigger than Big Pharma.
What price is being the company that brings a Paradigm change to Cancer treatment to market worth ? More than money involved, status is at stake.
Pinched from TOM on Twitter ... https://x.com/tom_the_bomb__/status/1702309376063627346?s=20
I saw this on Twitter & as with all new approach's it has it's for & against argument.
In my mind it some way mirrors the Covid PCR / LFT argument. You have on the one hand a complex probably expensive bit of kit that needs to be calibrated, stored, maintained, used in a hospital environment and administered by trained staff, all possible but adding to the overall ease of use and cost.
On the other hand a gel in a tube that you squeeze into the nose.
Protect your home from hidden water leaks
Receive a free LeakBot® smart water leak detector worth £149 with your SELECT Premier home buildings insurance.
Call us on 0345 246 8859
See terms and conditions
Get a quote
Understate over deliver looks like the way ahead :)
With 2m cu ft off-line & the new well still being nursed you would have to say 10m cu ft is looking good for when all 3 are up and running.
Credit where credit is due, GL got Saltfleetby over the line, no mean feat in itself which has allowed RH to join and push Angus to new heights.
The future looks a lot more inked in than it did a few months ago.
Off shore oil & gas going on strike from the 24th of April ?